Alexar Therapeutics, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Alexar Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2020).
SEC Form D · Apr 2020
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Apr 2020
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Alexar Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Pfeiffer | Executive officer | Apr 2020 |
| Stephen Tullman | Executive officer | Apr 2020 |
| Douglas Gessl | Executive officer | Jan 2019 |
| Kamil Ali-Jackson | Executive officer | Apr 2015 |
| Raju Mohan | Executive officer | Apr 2015 |
| David Pfeiffer | Director | Apr 2020 |
| Jason Hong | Director | Apr 2020 |
| Neal Walker | Director | Apr 2020 |
| Somasundaram Subramaniam | Director | Apr 2020 |
| Stephen Tullman | Director | Apr 2020 |
| Somu Subramaniam | Director | Jun 2017 |